| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.096 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |